11.01.2015 Views

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The Opioid Pendulum<br />

Opioid Abuse and Addiction<br />

Opiophobia<br />

Balance of Addiction<br />

Medic<strong>in</strong>e and Pa<strong>in</strong><br />

Management<br />

Pr<strong>in</strong>ciples 1<br />

Opiophillia<br />

• In past, estimated ˂1% of <strong>in</strong>dividuals treated for<br />

pa<strong>in</strong> became addicted to opioids<br />

• Now estimated 6%-15% of Americans addicted to<br />

drugs<br />

• 2010: estimated 22.1 million Americans, or 8.7% of<br />

the population of persons ≥ age 12 have substance<br />

dependence and abuse<br />

1 Gourlay, D.L. et al. (2005). Universal precautions <strong>in</strong> pa<strong>in</strong> medic<strong>in</strong>e: A rational approach to the treatment of<br />

chronic pa<strong>in</strong>. Pa<strong>in</strong> Medic<strong>in</strong>e, 6(2), 107-112.<br />

Marks RM, et al. Ann Intern Med. 1973;78:173-181.<br />

Commonly Used Terms<br />

What are the differences<br />

• Physical dependence: Withdrawal syndrome would occur if<br />

medication discont<strong>in</strong>ued abruptly, dose reduced rapidly, or<br />

antagonist adm<strong>in</strong>istered 1,2<br />

• Tolerance: Greater amount of medication needed to ma<strong>in</strong>ta<strong>in</strong><br />

therapeutic effect, or loss of effect over time 2<br />

• Pseudoaddiction: Behavior suggestive of addiction caused by<br />

undertreatment of pa<strong>in</strong> 2 ; can be major barrier to appropriate<br />

treatment of patients <strong>in</strong> pa<strong>in</strong><br />

• Addiction (psychological dependence): Biopsychosocial<br />

disorder characterized by cont<strong>in</strong>ued compulsive use of substance<br />

despite harm 2,3<br />

Who is abus<strong>in</strong>g prescription opioids<br />

We don’t know specific subpopulations who are<br />

abus<strong>in</strong>g…do they <strong>in</strong>clude<br />

• Persons who abuse or are dependent on only prescription<br />

opioids<br />

• Hero<strong>in</strong> abusers who use prescription opioids when hero<strong>in</strong><br />

unavailable<br />

• Abusers of other drugs who abuse opioids either alone (for<br />

alternative high) or <strong>in</strong> comb<strong>in</strong>ation with other drugs (poly-drug<br />

abuse)<br />

• Pa<strong>in</strong> patients who, dur<strong>in</strong>g course of legitimate treatment,<br />

develop iatrogenic addiction<br />

• Number thought to be low, but def<strong>in</strong>itive studies unavailable<br />

1. APS. Guidel<strong>in</strong>e for the Management of Cancer Pa<strong>in</strong> <strong>in</strong> Adults and Children. Glenview, Ill: American Pa<strong>in</strong> Society; 2005.<br />

2. Savage SR et al. APS Consensus Statement. Glenview, Ill: American Pa<strong>in</strong> Society; 2001. 3. Fishba<strong>in</strong> DA et al. Cl<strong>in</strong> J Pa<strong>in</strong>. 1992;8:77-85.<br />

Aberrant Drug-Related<br />

Behaviors<br />

Probably more predictive<br />

• Sell<strong>in</strong>g prescription drugs<br />

• Prescription forgery<br />

• Steal<strong>in</strong>g or borrow<strong>in</strong>g another patient’s drugs<br />

• Inject<strong>in</strong>g oral formulation<br />

• Obta<strong>in</strong><strong>in</strong>g prescription drugs from non-medical sources<br />

• Concurrent abuse of related illicit drugs<br />

• Multiple unsanctioned dose escalations<br />

• Recurrent prescription losses<br />

Aberrant Drug-Related<br />

Behaviors (cont.)<br />

Probably less predictive<br />

• Aggressive compla<strong>in</strong><strong>in</strong>g about need for higher doses<br />

• Drug hoard<strong>in</strong>g dur<strong>in</strong>g periods of reduced symptoms<br />

• Request<strong>in</strong>g specific drugs<br />

• Acquisition of similar drugs from other medical sources<br />

• Unsanctioned dose escalation 1-2 times<br />

• Unapproved use of drug to treat another symptom<br />

• Report<strong>in</strong>g psychic effects not <strong>in</strong>tended by cl<strong>in</strong>ician<br />

Passik and Portenoy, 1998.<br />

Passik and Portenoy, 1998.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!